Cargando…
Rapid implementation of extreme hypofractionation protocols in prostate cancer using RapidPlan® in response to COVID-19
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474808/ https://www.ncbi.nlm.nih.gov/pubmed/32898562 http://dx.doi.org/10.1016/j.radonc.2020.08.031 |
| _version_ | 1783579392141688832 |
|---|---|
| author | Martell, Kevin McGeachy, Philip Quon, Harvey Quirk, Sarah Roumeliotis, Michael Husain, Siraj Meyer, Tyler Sia, Michael Thind, Kundan |
| author_facet | Martell, Kevin McGeachy, Philip Quon, Harvey Quirk, Sarah Roumeliotis, Michael Husain, Siraj Meyer, Tyler Sia, Michael Thind, Kundan |
| author_sort | Martell, Kevin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7474808 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74748082020-09-08 Rapid implementation of extreme hypofractionation protocols in prostate cancer using RapidPlan® in response to COVID-19 Martell, Kevin McGeachy, Philip Quon, Harvey Quirk, Sarah Roumeliotis, Michael Husain, Siraj Meyer, Tyler Sia, Michael Thind, Kundan Radiother Oncol Letter to the Editor Elsevier B.V. 2020-10 2020-09-06 /pmc/articles/PMC7474808/ /pubmed/32898562 http://dx.doi.org/10.1016/j.radonc.2020.08.031 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Martell, Kevin McGeachy, Philip Quon, Harvey Quirk, Sarah Roumeliotis, Michael Husain, Siraj Meyer, Tyler Sia, Michael Thind, Kundan Rapid implementation of extreme hypofractionation protocols in prostate cancer using RapidPlan® in response to COVID-19 |
| title | Rapid implementation of extreme hypofractionation protocols in prostate cancer using RapidPlan® in response to COVID-19 |
| title_full | Rapid implementation of extreme hypofractionation protocols in prostate cancer using RapidPlan® in response to COVID-19 |
| title_fullStr | Rapid implementation of extreme hypofractionation protocols in prostate cancer using RapidPlan® in response to COVID-19 |
| title_full_unstemmed | Rapid implementation of extreme hypofractionation protocols in prostate cancer using RapidPlan® in response to COVID-19 |
| title_short | Rapid implementation of extreme hypofractionation protocols in prostate cancer using RapidPlan® in response to COVID-19 |
| title_sort | rapid implementation of extreme hypofractionation protocols in prostate cancer using rapidplan® in response to covid-19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474808/ https://www.ncbi.nlm.nih.gov/pubmed/32898562 http://dx.doi.org/10.1016/j.radonc.2020.08.031 |
| work_keys_str_mv | AT martellkevin rapidimplementationofextremehypofractionationprotocolsinprostatecancerusingrapidplaninresponsetocovid19 AT mcgeachyphilip rapidimplementationofextremehypofractionationprotocolsinprostatecancerusingrapidplaninresponsetocovid19 AT quonharvey rapidimplementationofextremehypofractionationprotocolsinprostatecancerusingrapidplaninresponsetocovid19 AT quirksarah rapidimplementationofextremehypofractionationprotocolsinprostatecancerusingrapidplaninresponsetocovid19 AT roumeliotismichael rapidimplementationofextremehypofractionationprotocolsinprostatecancerusingrapidplaninresponsetocovid19 AT husainsiraj rapidimplementationofextremehypofractionationprotocolsinprostatecancerusingrapidplaninresponsetocovid19 AT meyertyler rapidimplementationofextremehypofractionationprotocolsinprostatecancerusingrapidplaninresponsetocovid19 AT siamichael rapidimplementationofextremehypofractionationprotocolsinprostatecancerusingrapidplaninresponsetocovid19 AT thindkundan rapidimplementationofextremehypofractionationprotocolsinprostatecancerusingrapidplaninresponsetocovid19 |